All In Biotech

Free tool

FAERS Monitor: Actos

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021073 or its brand name (Actos, Pioglitazone Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

43,198

Serious

30,844

71% of reports

Hospitalization

11,767

Death reported

4,332

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • bladder cancer8,740
  • blood glucose increased3,398
  • nausea3,007
  • weight decreased2,092
  • diarrhoea1,757
  • death1,553
  • fatigue1,532
  • drug ineffective1,513
  • vomiting1,495
  • dyspnoea1,426
  • dizziness1,422
  • decreased appetite1,420
  • weight increased1,303
  • blood glucose decreased1,207
  • asthenia1,182

Reports by year received

View as table
YearReports
2004870
20051,323
20062,362
20072,679
20081,644
20091,880
20102,186
20113,106
20122,039
20131,282
20141,127
20156,601
20163,836
20171,859
20181,860
20191,684
20201,378
20211,090
2022984
2023906
2024952
2025913
2026637

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,010,961 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
bladder cancerSignal8,74084.782.9617,172
blood glucose decreasedSignal1,20712.511.812,499
blood glucose increasedSignal3,3988.98.623,682
weight decreasedSignal2,0923.73.54,082
decreased appetiteSignal1,4203.02.81,887
weight increasedSignal1,3032.82.71,563
nausea3,0071.91.81,222
vomiting1,4951.51.5297
asthenia1,1821.51.4221
dizziness1,4221.41.3158
diarrhoea1,7571.31.3145
dyspnoea1,4261.21.261
fatigue1,5321.00.93
death1,5530.90.828
drug ineffective1,5130.60.5562

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.